Concepedia

Mark Joing

MJ

Statistics

Publications

4

Citations

227

H-Index

4

Active since

2010

Affiliations

Johns Hopkins University(Current)

Mark Joing is an author at Johns Hopkins University specializing in medicine, pruritic skin disease, and pharmacotherapy.

Publications per year

2010–2025

4

Publications

4

Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial

Albert S. Chiou, Sara Choi, M. Barriga et al. · Journal of the American Academy of Dermatology · 2019 · 73 citations · Full text

, , +9

Recombinant human granulocyte– colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial

Abey Eapen, Mark Joing, Paul O Kwon et al. · Human Reproduction · 2019 · 64 citations · Full text

, , +13

Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO)

Sukgu M. Han, Fred A. Weaver, Anthony J. Comerota et al. · Journal of Vascular Surgery · 2010 · 54 citations

, , +4

Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies

Beryl B. Cummings, Mark Joing, Page Bouchard et al. · The Lancet · 2025 · 36 citations

, , +15

1–4 of 4